Trial
NCT04311294
Development of a Selective ALDH2 Inhibitor to Treat AUD
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of California, Los Angeles
Collaborators
Amygdala Neurosciences; National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Condition
Alcohol Use Disorder
Intervention
ANS-6637 Low Dose
Why stopped
Project was not funded.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-05-25